N@N

Ryan Zimmerman Downgraded (ZBH) to Hold on, Jan 10th, 2022

Ryan Zimmerman of BTIG, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold on, Jan 10th, 2022.

Ryan has made no other calls on ZBH in the last 4 months.

There are 12 other peers that have a rating on ZBH. Out of the 12 peers that are also analyzing ZBH, 5 agree with Ryan's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
• Matt O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022
• Shagun Singh of "RBC Capital" Initiated at Hold and Held Target at $140 on, Friday, December 10th, 2021
• David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021
• Pito Chickering of "Deutsche Bank" Maintained at Hold with Decreased Target to $140 on, Friday, November 5th, 2021

These are the ratings of the 7 analyists that currently disagree with Ryan

---

• Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $145 on, Tuesday, December 21st, 2021
• Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $150 on, Wednesday, December 15th, 2021
• Mike Matson of "Needham" Downgraded at Strong Buy and Decreased Target to $158 on, Thursday, December 9th, 2021
• Jason Wittes of "Loop Capital" Initiated at Strong Buy and Held Target at $165 on, Tuesday, December 7th, 2021
• David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $175 on, Friday, November 5th, 2021
• Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021
• Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 5th, 2021

Contributing Sources

---